Clinical Trial Update: Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating entecavir/pegylated interferon in immune-tolerant children with chronic hepatitis B; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Entecavir / Pegylated Interferon

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2018-07-03